Tech options, and finish with those before considering new technology.Įxample: University Medical Center Groningen’s evaluation and pipelineĬouto, Natacha, Leonard Schuele, Erwin C. ◦ New technologies and methods are constantly being released. ◦ This may take a while, and people graduate, move, get promoted, etc. ◦ Synthetic data / Contrived samples designed to test edge cases ◦ On real data / samples from 3rd party sources ◦ On real data / samples from your own lab BENCHMARK – in all three of these contexts.◦ Conduct an internal “Best of Breed” review of popular options ◦ Do yourself a favor, and don’t tackle everything at once FOCUS on individual steps in the workflow.Inocucor Technologies Vedanta Biosciences Lack of transparency for methods / algosĪ list of companies in this space was recently posted to my blog:Īdvanced Biological Laboratories (ABL) Maat Pharmaĭupont Nutrition & Health Reckitt Benckser.Less control over implementation and data.May not have validation for your pathogen.Over 110 companies now offer some form of End-to-End Microbial Cell-Free DNA Sequencing Test for Infectious Disease.” Nature Microbiology, February 11, 2019. 12 (December 2016): 2857–65.īlauwkamp, Timothy A., Simone Thair, Michael J. “Assuring the Quality of Next-Generation Sequencing in Clinical Microbiology and Public Health Laboratories.” Edited by C. Government testing labs, university core labs, etc. hospital microbiology labs, public health labs, A brief comment on Storage, Archive, and Backup What’s the “Process to build a Process” for Microbial Genomics ?Ģ. To a growing ecosystem of tools and databases to support microbial genomics researchįor more information, visit QIAGEN Bioinformaticsġ.
The QIAGEN Microbial Insight AR database (QMI-AR) and ARESdb are the latest additions QIAGEN does not guarantee the accuracy or reliability of the information provided herein. Represent the opinions or position of QIAGEN, or any other business unit associated with QIAGEN. Presenter, Jonathan Jacobs, an employee of QIAGEN N.V. The opinions expressed in this presentation and on the following slides are solely those of the Best Practices for Building an End-to-End Workflow for Microbial GenomicsĬurrent Testing Approaches & Implications for Public Health
0 kommentar(er)
